LCD L36021: MolDX: Molecular Diagnostic Tests (MDT) — CGS
Policy LCD-L36021 · Clinical Laboratory
New MolDX policy effective in 2025 may alter billing processes.
Code intelligence
0326U reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code 0326U.
Elevated code risk
Signal breakdown
6 shown · 6 total in platform
Risk: Elevated
0
Critical
0%
3
High
50%
3
Routine
50%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
High
LCD L36256: MolDX: Molecular Diagnostic Tests (MDT) — Noridian
Policy LCD-L36256 · Clinical Laboratory
New molecular diagnostics policy may impact billing processes.
LCD L35160: MolDX: Molecular Diagnostic Tests (MDT) — Noridian
Policy LCD-L35160 · Clinical Laboratory
New MolDX guidelines may alter MDT billing processes.
LCD L39232: MolDX: Plasma-Based Genomic Profiling in Solid Tumors — Noridian
Policy LCD-L39232 · Oncology
New genomic profiling coverage supports compliance with updated rates.
LCD L39230: MolDX: Plasma-Based Genomic Profiling in Solid Tumors — Noridian
Policy LCD-L39230 · Oncology
New LCD may transform oncology billing with advanced testing.
LCD L38065: MolDX: Plasma-Based Genomic Profiling in Solid Tumors — CGS
Policy LCD-L38065 · Oncology
New LCD affects billing for genomic profiling in tumors.
Audit documentation
Building an audit file that includes 0326U?
The Tripwire Audit Pack exports 12 months of Clinical Laboratory policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Clinical Laboratory audit pack — $349One-time purchase · not a subscription